Fusion proteins in head and neck neoplasms: Clinical implications, genetics, and future directions for targeting
Escalante D, Wang H, Fundakowski C. Fusion proteins in head and neck neoplasms: Clinical implications, genetics, and future directions for targeting. Cancer Biology & Therapy 2016, 17: 995-1002. PMID: 27636353, PMCID: PMC5079396, DOI: 10.1080/15384047.2016.1219823.Peer-Reviewed Original ResearchNeck neoplasmsClinical implicationsTyrosine kinase inhibitor dasatinibCell lung cancerTreatment of headChronic myeloid leukemiaBCR-ABL fusionKinase inhibitor dasatinibLung cancerNovel fusion proteinHematologic malignanciesMyeloid leukemiaMidline headSolid neoplasmsDiagnostic targetingNeoplasmsInhibitor dasatinibFusion proteinDiagnostic opportunitiesBiological behaviorSalivary glandsTherapeutic triumphsNeck structuresMalignancyPathogenesis